(Q44755518)

6 December 2017

title

Iopanoic acid in the management of neonatal Graves' disease (English)

1 reference

6 December 2017

Sonja M Earles

1

1 reference

6 December 2017

Peter M Gerrits

series ordinal

2

1 reference

6 December 2017

David J Transue

series ordinal

3

1 reference

6 December 2017

publication date

1 February 2004

1 reference

6 December 2017

published in

Journal of Perinatology

1 reference

6 December 2017

volume

24

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

105-108

1 reference

6 December 2017

cites work

Neonatal thyrotoxicosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

Thyroid Development and Disorders of Thyroid Function in the Newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

Roentgenographic Contrast Agents Inhibit Triiodothyronine Binding to Nuclear Receptors in Vitro*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

The Effect of Repeated Administration of Ipodate (Oragrafin) in Hyperthyroidism*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

Long term treatment of Graves' hyperthyroidism with sodium ipodate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

Management of neonatal Graves disease with iopanoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Pregnancy-Associated Changes in the Thyroid-Stimulating Antibody of Graves’ Disease and the Relationship to Neonatal Hyperthyroidism*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Fetal hyperthyroidism: experience of treatment in four siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Total and free triiodothyronine and thyroxine in early infancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Changes in Circulating Iodothyronines in Euthyroid and Hyperthyroid Subjects Given Ipodate (Oragrafin), an Agent for Oral Cholecystography*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Long term treatment of Graves' disease with iopanoic acid (Telepaque)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211046

7 January 2021

Identifiers

DOI

10.1038/SJ.JP.7211046

1 reference

Dimensions Publication ID

6 December 2017

1017418827

0 references

1 reference